BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Policy

  Sun BioPharma Announces U.S. FDA Grants IND For SBP-101 Pancreas Special Effect First in-Class Compound

  August 31, 2015

   · 

  3 min read
• Policy

  Titan Pharmaceuticals Announces Resubmission Of The New Drug Application For Probuphine For The Maintenance Treatment Of Opioid Addiction

  August 31, 2015

   · 

  5 min read
• Drug Development

  Corbus Commences Patient Enrollment In Phase 2 Clinical Study Of Resunab For The Treatment Of Systemic Sclerosis

  August 31, 2015

   · 

  7 min read
• Pharm Country

  IlluminOss Medical Inc.'s First-of-Its-Kind Bone Stabilization System Used In Treatment Of Rhode Island Hospital Patient

  August 31, 2015

   · 

  4 min read
• Deals

  Therapeutic Solutions International Acquires Preterm Labor And Miscarriage Intellectual Property From OmniBiome Therapeutics

  August 31, 2015

   · 

  3 min read
• TSO3 Inc. To Present At The 4th Annual Liolios Gateway Conference On September 10, 2015

  August 31, 2015

   · 

  2 min read
• Genetown

  MIT Release: Possible New Weapon Against PTSD

  August 31, 2015

   · 

  4 min read
• Deals

  South San Francisco’s CytomX Files for $100 Million IPO

  August 31, 2015

   · 

  2 min read
• Drug Development

  Alnylam And The Medicines Company Release: ALN-PCSsc Achieves Quarterly And Potentially Bi-Annual Subcutaneous Dose Regimen Profile For Effective LDL-C Lowering In Phase I Clinical Study

  August 31, 2015

   · 

  9 min read
• Drug Development

  TiGenix’s Cx601 Meets Primary Endpoint in Phase III Study

  August 31, 2015

   · 

  5 min read